The company’s OBPM algorithms use optical sensors worn on the wrist. Credit: StockSnap / Pixabay.

Aktiia has announced plans to launch its automated 24/7 blood pressure monitor in the US.

The new device is designed to automatically gather more than 100 times the blood pressure data of other monitors and also provides ten times more engagement.

The company’s Optical Blood Pressure Monitoring (OBPM) algorithms use optical sensors which are worn on the wrist.

Using photoplethysmography (PPG), these sensors provide blood pressure values by analysing the change in artery diameter that occurs at each heartbeat.

The measurements are done automatically, and users are not required to interrupt their day to take readings.

The data can be viewed instantly in a mobile app and easily shared with a physician or family member.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Aktiia noted that this automated approach removes the patient’s daily burden of measuring blood pressure values and allows them to focus on cardiovascular health improvement.

The blood pressure monitoring system received CE-mark as a Class IIa medical device in January last year and is currently available in seven European countries.

Aktiia announced a landmark hypertension trial in collaboration with Brigham and Women’s Hospital (BWH) in the US.

As of now, more than 3,000 participants have been enrolled in the BWH Remote Hypertension Programme.

BWH hypertension service director, consultant and advisor to Aktiia, and Harvard Medical School associate professor of medicine Dr Naomi Fisher said: “Hypertension affects nearly half of Americans, every hour of every day. Yet current measurement devices only capture a brief snapshot of overall blood pressure, and they are burdensome to use.

“The COOL-BP study will test an optical cuffless technology in BWH’s remote hypertension management programme.  An innovation that automatically provides blood pressure readings continually through days and nights holds tremendous promise in our efforts to control hypertension, both for individuals and for global health.”